Cobra to supply plasmids to UK COVID-19 vaccine developer 06-Oct-2020 By Jane Byrne Contract development and manufacturing organization (CDMO), Cobra Biologics, has been selected to manufacture plasmids for a Phase I clinical trial of a COVID-19 vaccine being developed by UK company, Scancell.